Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Rheumatic Heart Disease IV: Nursing Management

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Hospital financing in 2016. Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2016

Same author

[Hospital financing in 2015. Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2015

Same author

[Hospital financing in 2014. Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2014

Same author

[Hospital financing in 2013: relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2013

Same author

[Hospital financing in 2012 - Relevant changes for rheumatology].

Zeitschrift fur Rheumatologie·2012

Same author

[Hospital financing for 2011: relevant changes in rheumatology].

Zeitschrift fur Rheumatologie·2011

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

[The G-DRG system 2008. Relevant changes for rheumatology].

W Fiori¹, H-J Lakomek, K Buscham

¹DRG-Research-Group, Universitätsklinikum Münster, Domagkstrasse 20, 48129 Münster. wolfgang.fiori@smc.uni-muenster.de

Zeitschrift Fur Rheumatologie

|March 28, 2008

Summary

This summary is machine-generated.

The 2008 German Diagnosis Related Groups (G-DRG) system introduced significant changes impacting rheumatology departments. Hospitals must analyze economic effects to understand financial implications and potential funding shortfalls.

Related Experiment Videos

Last Updated: Jul 6, 2026

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

Area of Science:

Healthcare Management
Health Economics
Rheumatology

Context:

The German Diagnosis Related Groups (G-DRG) system underwent significant revisions for 2008.
These changes affect the financial management and resource allocation within German hospitals, particularly rheumatology departments.

Purpose:

To outline the general and specific modifications within the 2008 G-DRG system.
To detail changes in diagnosis and procedure classification and invoicing for 2008.
To guide rheumatology departments in analyzing the economic impact of the G-DRG system.

Summary:

The 2008 G-DRG system introduces substantial changes to German rheumatology departments, affecting diagnosis and procedure classifications and invoicing.
Hospitals are advised to utilize the G-DRG transition grouper to assess the economic consequences of these changes on their specific cases.
The financial impact can vary, with potential positive or negative effects depending on a department's clinical focus.

Impact:

Highlights the need for hospitals to conduct thorough economic analyses of the G-DRG system's effects.
Emphasizes that the G-DRG system is a resource redistribution tool, separate from funding adequacy for increased costs.
Informs rheumatology departments about potential financial shifts and the importance of independent economic evaluation.